For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress
Featuring perspectives from Dr Reva Basho, Ms Kelly Fischer, Ms Melissa Rikal and Dr Seth Wander, moderated by Dr Wander, including the following topics:
- Introduction (00:00)
- Identification of Appropriate Candidates for Agents Targeting the PI3K/AKT/mTOR Pathway (3:45)
- Role of Inavolisib in HR-Positive Metastatic Breast Cancer (mBC) (13:00)
- Strategies to Prevent and Manage Hyperglycemia (27:02)
- Clinical Utility of Capivasertib for HR-Positive mBC (38:09)
- Mitigation and Management of Gastrointestinal Adverse Events (51:05)
- Management of Dermatologic Adverse Events (59:58)
- Potential Role of Gedatolisib in the Management of HR-Positive mBC (1:08:42)
- Monitoring and Management of Cytopenias (1:21:23)
You May Also Like

Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio

The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories

Ologies with Alie Ward
Alie Ward

BrainStuff
iHeartPodcasts

Het uur van de waarheid
VRT NWS

A hombros de gigantes
Radio 5

Bigfoot Eyewitness Radio
Vic Cundiff

Created to Reign
Cornwall Alliance for the Stewardship of Creation

Universe Today Podcast
Fraser Cain

John Michael Godier's Event Horizon
John Michael Godier
Community discussion